The company's strategic push into AI, machine learning, and Software as a Medical Device (SaaMD) is subject to new and evolving FDA regulations. This creates a need for investment in specialized compliance frameworks, validation processes, and regulatory expertise to ensure market access for these innovative technologies.
Filing excerpt
Additionally, certain of our new products incorporate innovations related to artificial intelligence, machine learning and software as a medical device, which are subject to emerging FDA oversight and regulation.
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
Regions named
sec-10kcomplianceBurdenGet every 10-K signal for Zimmer Biomet and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Zimmer Biomet this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/e22b0b2c-f2eb-4145-b8ed-e3ad7a1af7b7 returns this record as JSON. POST /v1/companies/enrich returns every signal for zimmerbiomet.com.
{
"signal_id": "e22b0b2c-f2eb-4145-b8ed-e3ad7a1af7b7",
"signal_type": "sec-10k",
"signal_subtype": "complianceBurden",
"detected_at": "2026-02-24T09:29:57.326+00:00",
"company": {
"name": "Zimmer Biomet",
"domain": "zimmerbiomet.com"
},
"data": {
"detail": "The company's strategic push into AI, machine learning, and Software as a Medical Device (SaaMD) is subject to new and evolving FDA regulations. This creates a need for investment in specialized compliance frameworks, validation processes, and regulatory expertise to ensure market access for these innovative technologies.",
"summary": "Facing emerging FDA oversight for new products using AI and machine learning.",
"excerpts": "Additionally, certain of our new products incorporate innovations related to artificial intelligence, machine learning and software as a medical device, which are subject to emerging FDA oversight and regulation.",
"relevance": 0.8,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1136869/000119312526059853/zbh-20251231.htm",
"filing_date": "2026-02-19",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "GRC tools needed",
"signal_category": "risk",
"regions_mentioned": [
"U.S."
],
"technologies_mentioned": [
"artificial intelligence",
"machine learning"
]
}
}
curl https://signals.autobound.ai/v1/signals/e22b0b2c-f2eb-4145-b8ed-e3ad7a1af7b7 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"zimmerbiomet.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.